Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Richard Alexander

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
Plos One|January 4, 2013
Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesisSheelu Varghese, Rebecca Whipple, Stuart S Martin, et al.
Journal of Translational Medicine|November 14, 2006
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatmentAnne M Lewis, Sheelu Varghese, Hui Xu, et al.
Annals of Surgical Oncology|February 4, 2012
Concepts of regional therapies for advanced malignancyT Clark Gamblin, H Richard Alexander, Robert Edwards, et al.
Annals of Surgical Oncology|March 5, 2013
Regional therapies for cancerT Clark Gamblin, H Richard Alexander, Robert Edwards, et al.
Pathology|November 14, 2014
Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patientsSandy Liu, Paul Staats, Michael Lee, et al.
World Journal of Gastroenterology|December 24, 2013
Nonalcoholic fatty liver disease is associated with benign gastrointestinal disordersSrinevas K Reddy, Min Zhan, H Richard Alexander, et al.
CA: a Cancer Journal for Clinicians|August 15, 2022
The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright futureJason M Foster, Chunmeng Zhang, Shahyan Rehman, et al.
Annals of Surgery|August 8, 2012
Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndromeJeffrey A Norton, Douglas L Fraker, H Richard Alexander, et al.
Annals of Surgical Oncology|October 25, 2019
Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface MalignanciesM Haroon Choudry, David L Bartlett, H Richard Alexander, et al.
World Journal of Surgical Oncology|September 28, 2022
Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseasesStephanie N Gregory, Audra A Satterwhite, H Richard Alexander, et al.
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Plos One|January 4, 2013
Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesisSheelu Varghese, Rebecca Whipple, Stuart S Martin, et al.
Journal of Translational Medicine|November 14, 2006
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatmentAnne M Lewis, Sheelu Varghese, Hui Xu, et al.
Annals of Surgical Oncology|February 4, 2012
Concepts of regional therapies for advanced malignancyT Clark Gamblin, H Richard Alexander, Robert Edwards, et al.
Annals of Surgical Oncology|March 5, 2013
Regional therapies for cancerT Clark Gamblin, H Richard Alexander, Robert Edwards, et al.
Pathology|November 14, 2014
Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patientsSandy Liu, Paul Staats, Michael Lee, et al.
World Journal of Gastroenterology|December 24, 2013
Nonalcoholic fatty liver disease is associated with benign gastrointestinal disordersSrinevas K Reddy, Min Zhan, H Richard Alexander, et al.
CA: a Cancer Journal for Clinicians|August 15, 2022
The contemporary management of peritoneal metastasis: A journey from the cold past of treatment futility to a warm present and a bright futureJason M Foster, Chunmeng Zhang, Shahyan Rehman, et al.
Annals of Surgery|August 8, 2012
Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndromeJeffrey A Norton, Douglas L Fraker, H Richard Alexander, et al.
Annals of Surgical Oncology|October 25, 2019
Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface MalignanciesM Haroon Choudry, David L Bartlett, H Richard Alexander, et al.
World Journal of Surgical Oncology|September 28, 2022
Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseasesStephanie N Gregory, Audra A Satterwhite, H Richard Alexander, et al.
Pageof 18